Molecular Partners AG -ADRMOLN
13F holders, Q3 2025 (September 30)6holders
0new positions
0sold out
$3.71avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Montanova Capital, LLC ($8.2M), BVF Inc. ($5.0M) and UBS Group AG ($20K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 114 shares bought and 4,860 shares sold, net −4,746 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Montanova Capital, LLC | 0.25% | No change | 2,221,494 | $8.2M |
| BVF Inc. | 0.20% | No change | 1,353,968 | $5.0M |
| UBS Group AG | 0.00% | Reduce -47.6% | 5,339 | $20K |
| Morgan Stanley | 0.00% | No change | 367 | $1K |
| Bank of America Corp. | 0.00% | No change | 157 | $582 |
| EverSource Wealth Advisors, LLC | 0.00% | Add +278.1% | 155 | $575 |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.